Palo Verde Hematology Oncology, Ltd. is a clinical research site located in Glendale, Arizona, United States 85304.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Palo Verde Hematology Oncology, Ltd. has participated in 2 clinical trials.
Therapeutic areas: Squamous Cell Carcinoma, Non-Small-Cell Lung, Cancer Cachexia.
Sponsors: Celgene, Helsinn Therapeutics (U.S.), Inc.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Palo Verde Hematology Oncology, Ltd. has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Palo Verde Hematology Oncology, Ltd. has 2 clinical trials on record. Their work covers Squamous Cell Carcinoma, Non-Small-Cell Lung, Cancer Cachexia.
Palo Verde Hematology Oncology, Ltd. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.